Duck Virus Enteritis Vaccine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240631

Publication Date:

September 24, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Vaccine for Duck Virus Enteritis, A听duck enteritis virus- vectored bivalent live听vaccine听provides fast and complete protection against H5N1 avian influenza听virus听infection in听ducks.
The global market for Duck Virus Enteritis Vaccine was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 97.9 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Duck Virus Enteritis Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Duck Virus Enteritis Vaccine by region & country, by Type, and by Application.
The Duck Virus Enteritis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Virus Enteritis Vaccine.
麻豆原创 Segmentation
By Company
Ceva Sant茅 Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Segment by Type:
Live Vaccines
Killed Vaccines
Segment by Application
Duck
Others
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Duck Virus Enteritis Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Duck Virus Enteritis Vaccine Product Introduction
1.2 Global Duck Virus Enteritis Vaccine 麻豆原创 Size Forecast
1.2.1 Global Duck Virus Enteritis Vaccine Sales Value (2019-2030)
1.2.2 Global Duck Virus Enteritis Vaccine Sales Volume (2019-2030)
1.2.3 Global Duck Virus Enteritis Vaccine Sales Price (2019-2030)
1.3 Duck Virus Enteritis Vaccine 麻豆原创 Trends & Drivers
1.3.1 Duck Virus Enteritis Vaccine Industry Trends
1.3.2 Duck Virus Enteritis Vaccine 麻豆原创 Drivers & Opportunity
1.3.3 Duck Virus Enteritis Vaccine 麻豆原创 Challenges
1.3.4 Duck Virus Enteritis Vaccine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Duck Virus Enteritis Vaccine Players Revenue Ranking (2023)
2.2 Global Duck Virus Enteritis Vaccine Revenue by Company (2019-2024)
2.3 Global Duck Virus Enteritis Vaccine Players Sales Volume Ranking (2023)
2.4 Global Duck Virus Enteritis Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Duck Virus Enteritis Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Duck Virus Enteritis Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Duck Virus Enteritis Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Duck Virus Enteritis Vaccine
2.9 Duck Virus Enteritis Vaccine 麻豆原创 Competitive Analysis
2.9.1 Duck Virus Enteritis Vaccine 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Duck Virus Enteritis Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Duck Virus Enteritis Vaccine Sales Value by Type
3.2.1 Global Duck Virus Enteritis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Duck Virus Enteritis Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Duck Virus Enteritis Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Duck Virus Enteritis Vaccine Sales Volume by Type
3.3.1 Global Duck Virus Enteritis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Duck Virus Enteritis Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Duck Virus Enteritis Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Duck Virus Enteritis Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Duck
4.1.2 Others
4.2 Global Duck Virus Enteritis Vaccine Sales Value by Application
4.2.1 Global Duck Virus Enteritis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Duck Virus Enteritis Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Duck Virus Enteritis Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Duck Virus Enteritis Vaccine Sales Volume by Application
4.3.1 Global Duck Virus Enteritis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Duck Virus Enteritis Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Duck Virus Enteritis Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Duck Virus Enteritis Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Duck Virus Enteritis Vaccine Sales Value by Region
5.1.1 Global Duck Virus Enteritis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Duck Virus Enteritis Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Duck Virus Enteritis Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Duck Virus Enteritis Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Duck Virus Enteritis Vaccine Sales Volume by Region
5.2.1 Global Duck Virus Enteritis Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Duck Virus Enteritis Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Duck Virus Enteritis Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Duck Virus Enteritis Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Duck Virus Enteritis Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.4.2 North America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.5.2 Europe Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.7.2 South America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value
6.2.1 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.3.2 United States Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.4.2 Europe Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.5.2 China Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.6.2 Japan Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.7.2 South Korea Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.9.2 India Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ceva Sant茅 Animale
7.1.1 Ceva Sant茅 Animale Company Information
7.1.2 Ceva Sant茅 Animale Introduction and Business Overview
7.1.3 Ceva Sant茅 Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ceva Sant茅 Animale Duck Virus Enteritis Vaccine Product Offerings
7.1.5 Ceva Sant茅 Animale Recent Development
7.2 Chengdu TECBOND Biological
7.2.1 Chengdu TECBOND Biological Company Information
7.2.2 Chengdu TECBOND Biological Introduction and Business Overview
7.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offerings
7.2.5 Chengdu TECBOND Biological Recent Development
7.3 Institute of Animal Health and Veterinary Biologicals
7.3.1 Institute of Animal Health and Veterinary Biologicals Company Information
7.3.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
7.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offerings
7.3.5 Institute of Animal Health and Veterinary Biologicals Recent Development
7.4 Institute of Veterinary Preventive Medicine
7.4.1 Institute of Veterinary Preventive Medicine Company Information
7.4.2 Institute of Veterinary Preventive Medicine Introduction and Business Overview
7.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offerings
7.4.5 Institute of Veterinary Preventive Medicine Recent Development
7.5 International Duck Research Cooperative
7.5.1 International Duck Research Cooperative Company Information
7.5.2 International Duck Research Cooperative Introduction and Business Overview
7.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offerings
7.5.5 International Duck Research Cooperative Recent Development
7.6 MSD Animal Health (Merck)
7.6.1 MSD Animal Health (Merck) Company Information
7.6.2 MSD Animal Health (Merck) Introduction and Business Overview
7.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offerings
7.6.5 MSD Animal Health (Merck) Recent Development
7.7 Ringpu (Tianjin)Bio-Pharmacy
7.7.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
7.7.2 Ringpu (Tianjin)Bio-Pharmacy Introduction and Business Overview
7.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offerings
7.7.5 Ringpu (Tianjin)Bio-Pharmacy Recent Development
7.8 Veterinary Research Institute
7.8.1 Veterinary Research Institute Company Information
7.8.2 Veterinary Research Institute Introduction and Business Overview
7.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offerings
7.8.5 Veterinary Research Institute Recent Development
8 Industry Chain Analysis
8.1 Duck Virus Enteritis Vaccine Industrial Chain
8.2 Duck Virus Enteritis Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Duck Virus Enteritis Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Duck Virus Enteritis Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Ceva Sant茅 Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.